Trials / Completed
CompletedNCT03921775
A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery
A Multicenter, Randomized, Single-blind, Parallel and Control Phase III Trial Evaluating the Efficacy and Safety of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of remimazolam tosilate compared to propofol for general anesthesia during elective surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Tosilate | For induction and maintenance of general anesthesia |
| DRUG | Propofol | For induction and maintenance of general anesthesia |
Timeline
- Start date
- 2019-05-13
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
- First posted
- 2019-04-19
- Last updated
- 2020-05-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03921775. Inclusion in this directory is not an endorsement.